Chandiramani, Rishi
Cao, Davide
Nicolas, Johny
Mehran, Roxana
Article History
Received: 2 March 2020
Accepted: 6 March 2020
First Online: 6 April 2020
Compliance with ethical standards
:
: Dr. Mehran reports receiving consulting fees from Abbott Vascular, Boston Scientific, Medscape/WebMD, Siemens Medical Solutions, Phillips/Volcano/Spectranetics, Roviant Sciences, Sanofi Italy, Bracco Group, Janssen, and AstraZeneca, grant support, paid to her institution, from Bayer, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich, Osprey Medical, PLC/RenalGuard, and Abbott Vascular, grant support and advisory board fees, paid to her institution, from BMS, fees for serving on a data and safety monitoring board from Watermark Research Funding, advisory fees and lecture fees from Medintelligence (Janssen), and lecture fees from Bayer. All other authors report no conflicts of interest.